Back

Performance of Abbott Architect, Ortho Vitros, and Euroimmun Assays in Detecting Prior SARS-CoV-2 Infection

Mahajan, S.; Redlich, C. A.; Wisnewski, A. V.; Fazen, L. E.; Rao, L. V.; Kuppusamy, K.; Ko, A. I.; Krumholz, H. M.

2020-07-30 infectious diseases
10.1101/2020.07.29.20164343
Show abstract

BackgroundSeveral serological assays have been developed to detect anti-SARS-CoV-2 IgG antibodies, but evidence about their comparative performance is limited. We sought to assess the sensitivity of four anti-SARS-CoV-2 IgG enzyme-linked immunosorbent assays (ELISA) in individuals with evidence of prior SARS-CoV-2 infection. MethodsWe obtained sera from 36 individuals with PCR-confirmed SARS-CoV-2 infection between March and May 2020. We evaluated samples collected at around 21 days ({+/-}14 days) after their initial PCR test using 3 commercially available ELISA assays, two anti-spike (Ortho- Clinical Diagnostics Vitros, and Euroimmun) and one anti-nucleocapsid (Abbott Architect), and a Yale-developed anti-spike ELISA test. We determined the sensitivity of the tests and compared their results. The Euroimmun and Yale ELISA had an equivocal and indeterminate category, which were considered as both negative and positive. ResultsAmong the 36 individuals with SARS-CoV-2 infection, mean age was 43 ({+/-}13) years and 19 (53%) were female. The sensitivities of the tests were not significantly different (Abbott Architect, Ortho Vitros, Euroimmmun, and Yale assays: 86% (95% confidence interval [CI], 71- 95), 94% (95% CI, 81-99), 86% (95% CI, 71-95), and 94% (95% CI, 81-99), respectively; p- value=0.464). The sensitivities of the Euroimmun and Yale ELISA tests increased when the equivocal/indeterminate results were considered positive (97% [95% CI, 85-100] and 100% [95% CI, 90-100], respectively), but were not significantly different from other tests (p=0.082). The cross-correlation coefficient ranged from 0.85-0.98 between three anti-spike protein assays (Ortho Vitros, Euroimmun, Yale) and was 0.58-0.71 between the three anti-spike protein assays and the anti-nucleocapsid assay (Abbott). ConclusionThe sensitivities of four anti-SARS-CoV-2 protein assays did not significantly differ, although the sample size was small. Sensitivity also depended on the interpretation of equivocal and indeterminate results. The strongest correlations were present for the three anti- spike proteins assays. These findings suggest that individual test characteristics and the correlation between different tests should be considered when comparing or aggregating data across different populations studies for serologic surveillance of past SARS-CoV-2 infection.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of Clinical Microbiology
based on 77 papers
Top 0.3%
16.0%
2
PLOS ONE
based on 1737 papers
Top 48%
10.6%
3
Journal of Clinical Virology
based on 54 papers
Top 0.2%
7.9%
4
Microbiology Spectrum
based on 86 papers
Top 0.2%
5.5%
5
Journal of Medical Virology
based on 95 papers
Top 2%
5.3%
6
International Journal of Infectious Diseases
based on 115 papers
Top 3%
3.1%
7
Journal of Virological Methods
based on 20 papers
Top 0.6%
3.1%
50% of probability mass above
8
Scientific Reports
based on 701 papers
Top 52%
2.9%
9
Clinical Infectious Diseases
based on 219 papers
Top 8%
2.9%
10
Clinical Microbiology and Infection
based on 54 papers
Top 1%
2.5%
11
Clinical Chemistry and Laboratory Medicine (CCLM)
based on 11 papers
Top 0.1%
2.5%
12
Open Forum Infectious Diseases
based on 124 papers
Top 4%
2.4%
13
The Journal of Infectious Diseases
based on 137 papers
Top 5%
1.9%
14
Infectious Diseases and Therapy
based on 18 papers
Top 0.4%
1.9%
15
Diagnostics
based on 36 papers
Top 2%
1.8%
16
Diagnostic Microbiology and Infectious Disease
based on 15 papers
Top 0.1%
1.6%
17
Frontiers in Medicine
based on 99 papers
Top 13%
1.4%
18
Emerging Infectious Diseases
based on 84 papers
Top 8%
1.4%
19
BMJ Open
based on 553 papers
Top 43%
1.4%
20
Clinical Chemistry
based on 14 papers
Top 0.8%
1.4%
21
Journal of Infection
based on 64 papers
Top 4%
1.4%
22
European Journal of Clinical Microbiology & Infectious Diseases
based on 14 papers
Top 0.6%
1.4%
23
Journal of Clinical Virology Plus
based on 10 papers
Top 0.1%
1.2%
24
JAMA Network Open
based on 125 papers
Top 17%
0.8%
25
Heliyon
based on 57 papers
Top 10%
0.8%
26
Journal of Medical Microbiology
based on 14 papers
Top 0.8%
0.8%
27
Viruses
based on 79 papers
Top 5%
0.8%
28
Annals of Internal Medicine
based on 27 papers
Top 2%
0.8%
29
The Journal of Molecular Diagnostics
based on 24 papers
Top 2%
0.7%
30
BMC Infectious Diseases
based on 110 papers
Top 20%
0.7%